MedPath

Study on the efficacy of traditional Chinese medicine in the treatment of nonarteritis anterior ischemic optic neuropathy

Phase 1
Not yet recruiting
Conditions
nonarteritic anterior ischemic optic neuropathy
Registration Number
ITMCTR2022000062
Lead Sponsor
Eye Hospital of China Academy of Chinese Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) Comply with the diagnostic criteria of western medicine and traditional Chinese medicine;
(2) Age 50-80 years old, gender is not limited;
(3) The course of the disease is 1-5 months; if the patient has the onset of both eyes successively and the onset time of both eyes is 1-5 months, the latter eye will be selected and included in the group;
(4) Good control of blood pressure and blood sugar;
(5) Not participating in other clinical trials during treatment;
(6) Patients volunteered to participate in this research.

Exclusion Criteria

(1) Arteritis anterior ischemic optic neuropathy is excluded;
(2) Hormone therapy has been used within one week before enrollment;
(3) Suffering from other eye diseases or diopter exceeding ±6.00DS;
(4) Patients with recurrent NAION in one eye;
(5) Combined with other eye diseases;
(6) suffering from mental or neurological diseases;
(7) Dysfunction of important organs such as the heart, liver and kidney;
(8) Suffering from malignant tumor;
(9) Pregnant or lactating women;
(10) Participating in other relevant clinical investigators;
(11) Patients who refuse to sign informed consent.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.